H.R. 9277 aims to change the Administrative Procedure Act by stating that when courts review administrative actions, they cannot consider any evidence that is deemed unreliable or not based on sound scientific principles and methods. This means that only evidence that meets certain scientific standards can be used in judicial reviews of administrative decisions.
Supporters of H.R. 9277 argue that the bill will enhance the integrity of judicial reviews by ensuring that only credible scientific evidence is considered, potentially leading to more informed and reliable legal outcomes. Advocates believe this will help protect public health and safety by preventing the use of unverified or dubious scientific claims in court.
Critics of H.R. 9277 contend that the bill could undermine judicial reviews by excluding valuable evidence that may not yet meet strict scientific standards but is nonetheless relevant. They argue that this could hinder the ability of courts to make comprehensive decisions and could favor certain interests over others, potentially leading to unjust outcomes.
The analysis of H.R. 9277, sponsored by Harriet Hageman, reveals no direct industry overlaps between the subject matter of the bill and the sponsor's top donor industries. This suggests a low likelihood of conflicts of interest arising from financial contributions. The bill seeks to amend the Administrative Procedure Act regarding the admissibility of scientific evidence in judicial review, which does not appear to be directly influenced by the interests of Hageman's donors. Given that there are no overlapping industries, the potential for bias or undue influence from financial backers is minimal. Voters should be aware that while campaign contributions can sometimes lead to perceived conflicts, in this case, the absence of overlap indicates a lower risk of legislative bias.
Top industries funding Harriet Hageman, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
